• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名非酒精性脂肪性肝病患者因接触氯仿导致急性肝损伤:病例报告

Acute liver injury in a non-alcoholic fatty liver disease patient with chloroform exposure: a case report.

作者信息

Suehiro Yosuke, Uchida Takuro, Tsuge Masataka, Murakami Eisuke, Miki Daiki, Kawaoka Tomokazu, Imamura Michio, Aikata Hiroshi, Arihiro Koji, Oka Shiro

机构信息

Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi Minami-ku, Hiroshima, 734-8551, Japan.

Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan.

出版信息

Clin J Gastroenterol. 2023 Apr;16(2):250-253. doi: 10.1007/s12328-023-01760-7. Epub 2023 Jan 30.

DOI:10.1007/s12328-023-01760-7
PMID:36715860
Abstract

We report a rare case of acute liver injury by daily exposure to small amounts of chloroform in non-alcoholic fatty liver disease (NAFLD) patient. The patient had been followed up in our hospital every 3 months. Although his alanine aminotransferase (ALT) levels were steady around 30 ~ 60 U/L until August 2014, ALT level was spontaneously increased to more than 1,000 U/L at the follow-up point in late August 2014. As he was diagnosed as acute liver injury by chloroform exposure, we withdrew him from the exposure of chloroform and treated him with 600 mg/day of ursodeoxycholic acid. Afterwards, his ALT level rapidly improved and normalized within 1 month. To verify the influences of chloroform exposure, we measured plasma chloroform levels by gas chromatography. Although plasma chloroform concentration was 7.1 ng/ml (normal range: < 0.2 ng/ml) at the time of liver injury, the concentration had decreased to 0.7 ng/ml by 1 month later. Despite the fact that he had put on a face mask to protect from aspiration of chloroform, liver injury still occurred in the present case. Chloroform has a high solubility for lipids and accumulation of lipids in the liver might become a risk factor for liver injury by chloroform.

摘要

我们报告了一例非酒精性脂肪性肝病(NAFLD)患者因每日接触少量氯仿而发生急性肝损伤的罕见病例。该患者在我院每3个月接受一次随访。直到2014年8月,他的丙氨酸氨基转移酶(ALT)水平一直稳定在30~60 U/L左右,但在2014年8月下旬的随访中,ALT水平自发升高至1000 U/L以上。由于他被诊断为因接触氯仿导致急性肝损伤,我们让他停止接触氯仿,并给予他每日600毫克熊去氧胆酸进行治疗。此后,他的ALT水平迅速改善,并在1个月内恢复正常。为了验证氯仿接触的影响,我们通过气相色谱法测量了血浆氯仿水平。虽然在肝损伤时血浆氯仿浓度为7.1纳克/毫升(正常范围:<0.2纳克/毫升),但1个月后该浓度已降至0.7纳克/毫升。尽管他佩戴了面罩以防止吸入氯仿,但在本病例中仍发生了肝损伤。氯仿对脂质具有高溶解性,肝脏中脂质的积累可能成为氯仿导致肝损伤的一个危险因素。

相似文献

1
Acute liver injury in a non-alcoholic fatty liver disease patient with chloroform exposure: a case report.一名非酒精性脂肪性肝病患者因接触氯仿导致急性肝损伤:病例报告
Clin J Gastroenterol. 2023 Apr;16(2):250-253. doi: 10.1007/s12328-023-01760-7. Epub 2023 Jan 30.
2
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.度拉糖肽可降低 2 型糖尿病患者的血浆氨基转移酶,其模式与肝脂肪减少一致:AWARD 计划的事后分析。
Diabet Med. 2018 Oct;35(10):1434-1439. doi: 10.1111/dme.13697. Epub 2018 Jun 22.
3
Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels.非酒精性脂肪性肝病患儿肝组织学异常与丙氨酸氨基转移酶正常或轻度升高。
J Pediatr. 2014 Apr;164(4):707-713.e3. doi: 10.1016/j.jpeds.2013.10.071. Epub 2013 Dec 19.
4
[Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].[益生菌对非酒精性脂肪性肝病的治疗效果]
Zhonghua Nei Ke Za Zhi. 2018 Feb 1;57(2):101-106. doi: 10.3760/cma.j.issn.0578-1426.2018.02.004.
5
Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non-alcoholic fatty liver disease.修订血清 ALT 正常值上限有助于评估非酒精性脂肪性肝病肥胖儿童的轻度肝损伤。
J Clin Lab Anal. 2020 Jul;34(7):e23285. doi: 10.1002/jcla.23285. Epub 2020 Apr 8.
6
Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study.非肥胖中国人群中丙氨酸氨基转移酶/天冬氨酸氨基转移酶比值与新发非酒精性脂肪性肝病的关系:一项基于人群的纵向研究。
Lipids Health Dis. 2020 Nov 25;19(1):245. doi: 10.1186/s12944-020-01419-z.
7
Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015.韩国青少年的正常血清丙氨酸转氨酶与非酒精性脂肪性肝病:一项使用2010 - 2015年韩国国家健康与营养检查调查(KNHANES)数据的横断面研究
BMC Pediatr. 2018 Jul 5;18(1):215. doi: 10.1186/s12887-018-1202-z.
8
FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran.在伊朗班达尔阿巴斯,比较 FIB-4、APRI 和 AST/ALT 比值与 FibroScan 用于评估非酒精性脂肪性肝病患者的肝纤维化。
BMC Gastroenterol. 2021 Dec 3;21(1):453. doi: 10.1186/s12876-021-02038-3.
9
Successful Treatment of Rapid Onset, Symptomatic de novo Non-alcoholic Steatohepatitis Following Liver Transplantation: A Case Report.肝移植后新发快速起病、有症状的非酒精性脂肪性肝炎的成功治疗:一例报告
J Clin Exp Hepatol. 2013 Mar;3(1):70-4. doi: 10.1016/j.jceh.2013.01.001. Epub 2013 Jan 25.
10
Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm.转氨基酶浓度不能区分病态肥胖患者的非酒精性脂肪肝和非酒精性脂肪性肝炎,无论采用何种组织学算法。
Dig Dis. 2022;40(5):644-653. doi: 10.1159/000519317. Epub 2021 Sep 1.

本文引用的文献

1
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.2020 年非酒精性脂肪性肝病/非酒精性脂肪性肝炎临床实践循证指南。
J Gastroenterol. 2021 Nov;56(11):951-963. doi: 10.1007/s00535-021-01796-x. Epub 2021 Sep 17.
2
Nonalcoholic Fatty Liver Disease for the Incidence of Drug-Induced Liver Injury.非酒精性脂肪性肝病与药物性肝损伤的发生率
Clin Gastroenterol Hepatol. 2022 Apr;20(4):964-965. doi: 10.1016/j.cgh.2021.06.023. Epub 2021 Jun 24.
3
The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan.
日本全国性调查中肝细胞癌合并肝硬化病因的转变。
J Gastroenterol. 2021 Feb;56(2):158-167. doi: 10.1007/s00535-020-01748-x. Epub 2020 Nov 20.
4
Transition in the etiology of liver cirrhosis in Japan: a nationwide survey.日本肝硬化病因变迁:一项全国性调查。
J Gastroenterol. 2020 Mar;55(3):353-362. doi: 10.1007/s00535-019-01645-y. Epub 2019 Nov 25.
5
Patients With Chronic Liver Disease Suggestive of Nonalcoholic Fatty Liver Disease May Be at Higher Risk for Drug-Induced Liver Injury.有非酒精性脂肪性肝病特征的慢性肝病患者可能具有更高的药物性肝损伤风险。
Clin Gastroenterol Hepatol. 2019 Dec;17(13):2814-2815. doi: 10.1016/j.cgh.2018.12.013. Epub 2018 Dec 20.
6
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
7
Chloroform ingestion causing severe gastrointestinal injury, hepatotoxicity and dermatitis confirmed with plasma chloroform concentrations.摄入氯仿导致严重的胃肠道损伤、肝毒性和皮炎,血浆氯仿浓度可证实这一点。
Clin Toxicol (Phila). 2017 Feb;55(2):147-150. doi: 10.1080/15563650.2016.1249795. Epub 2016 Oct 28.
8
Acute liver injury in two workers exposed to chloroform in cleanrooms: a case report.洁净室中两名接触氯仿工人的急性肝损伤:病例报告
Ann Occup Environ Med. 2014 Nov 4;26(1):49. doi: 10.1186/s40557-014-0049-5. eCollection 2014.
9
Lethal complications after poisoning with chloroform--case report and literature review.氯仿中毒后的致命并发症——病例报告及文献综述
Hum Exp Toxicol. 2010 Jul;29(7):615-22. doi: 10.1177/0960327109357142. Epub 2010 Jan 5.
10
Mechanism of chloroform-induced renal toxicity: non-involvement of hepatic cytochrome P450-dependent metabolism.氯仿诱导肾毒性的机制:不涉及肝细胞色素P450依赖性代谢。
Toxicol Appl Pharmacol. 2008 Feb 15;227(1):48-55. doi: 10.1016/j.taap.2007.10.014. Epub 2007 Oct 23.